Clinical
Clinical Trial Strategy & Planning
In-depth expertise to demonstrate device safety and efficacy — and to make sure the clinical evidence you collect is exactly what your submission requires.
What We Do
We develop clinical strategy and plans that are built around your regulatory pathway, not bolted on afterward. That includes protocol development, endpoint selection, IDE strategy where required, post-trial support, and international applications. We coordinate with the people who matter — FDA, Notified Bodies, competent authorities, principal investigators, institutional review boards, and ethics committees — so the study runs cleanly and the data lands where your 510(k), De Novo, PMA, or EU clinical evaluation needs it.
Services
- · Protocol development
- · IDE strategy & submission support
- · Endpoint & pathway alignment
- · Post-trial support
- · International clinical applications
- · IRB / ethics committee coordination
- · Notified Body & competent authority liaison
- · Investigator coordination
Integrated With Your Whole Program
Clinical strategy is most powerful when it is connected to regulatory and quality from day one. Because we run the submission and the quality system too — and our family generates the bench, sterilization, and package data alongside — your clinical plan is designed as part of one coherent route to market, not as an isolated study.
Frequently Asked Questions
When does a medical device need clinical data?
Most 510(k)s do not require clinical data, but De Novo and PMA submissions usually do, as do many EU MDR clinical evaluations where existing evidence is insufficient. We help you determine early whether clinical data is required and, if so, design the most efficient study to generate it.
What is an IDE?
An Investigational Device Exemption (IDE) allows a device to be used in a clinical study to collect the safety and effectiveness data needed for a PMA or certain 510(k)/De Novo submissions. We support IDE strategy and align it with your overall regulatory plan so the data you collect is the data your submission needs.
Do you run the trials or plan them?
We focus on clinical strategy and planning — protocol development, endpoint and pathway alignment, and coordination with FDA, Notified Bodies, IRBs/ethics committees, and investigators. We integrate the clinical plan with your regulatory submission and quality system so the pieces reinforce each other.
Planning a Clinical Study?
Let’s make sure your clinical evidence matches your regulatory pathway from the start.
Request a ConsultThe Boulder BioMed Family
One campus, one quality system. We manufacture, sterilize, and test medical devices in-house — so our regulatory and quality work is grounded in operations, not theory.